Abbott Laboratories (ABT) EPS (Weighted Average and Diluted) (2009 - 2026)
Abbott Laboratories recorded quarterly EPS (Weighted Average and Diluted) of $0.61 in Q1 2026, down 40.2% quarter-over-quarter from $1.02 in Q4 2025, and down 19.74% year-over-year from $0.76 in Q1 2025.
Abbott Laboratories' EPS (Weighted Average and Diluted) history runs 18 years deep, the most recent figure standing at $0.61 for Q1 2026.
- In Q1 2026, EPS (Weighted Average and Diluted) fell 19.74% year-over-year to $0.61; the TTM figure through Mar 2026 stood at $3.58 (down 53.51% YoY), while the FY2025 annual figure was $3.72, down 51.31% from the prior year.
- EPS (Weighted Average and Diluted) came in at $0.61 for Q1 2026 at Abbott Laboratories, down from $1.02 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $5.26 in Q4 2024 to a low of $0.59 in Q4 2022.
- A 5-year average of $1.13 and a median of $0.82 in 2023 frame the typical range for EPS (Weighted Average and Diluted).
- Across the five-year window, EPS (Weighted Average and Diluted) jumped 478.02% in 2024 and plunged 80.61% in 2025, its largest moves.
- Abbott Laboratories' EPS (Weighted Average and Diluted) stood at $0.59 in 2022, then jumped by 54.24% to $0.91 in 2023, then soared by 478.02% to $5.26 in 2024, then tumbled by 80.61% to $1.02 in 2025, then slumped by 40.2% to $0.61 in 2026.
- According to Business Quant data, EPS (Weighted Average and Diluted) over the past three periods registered $0.61, $1.02, and $0.94 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.61 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 1.93 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.89 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.66 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.51 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.85 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 2.24 |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | 1.22 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.61 |
| Dec 31, 2025 | 1.02 |
| Sep 30, 2025 | 0.94 |
| Jun 30, 2025 | 1.01 |
| Mar 31, 2025 | 0.76 |
| Dec 31, 2024 | 5.26 |
| Sep 30, 2024 | 0.94 |
| Jun 30, 2024 | 0.74 |
| Mar 31, 2024 | 0.70 |
| Dec 31, 2023 | 0.91 |
| Sep 30, 2023 | 0.82 |
| Jun 30, 2023 | 0.78 |
| Mar 31, 2023 | 0.75 |
| Dec 31, 2022 | 0.59 |
| Sep 30, 2022 | 0.81 |
| Jun 30, 2022 | 1.14 |
| Mar 31, 2022 | 1.37 |
| Dec 31, 2021 | 1.11 |
| Sep 30, 2021 | 1.17 |
| Jun 30, 2021 | 0.66 |
| Mar 31, 2021 | 1.00 |
| Dec 31, 2020 | 1.20 |
| Sep 30, 2020 | 0.69 |
| Jun 30, 2020 | 0.30 |
| Mar 31, 2020 | 0.31 |
| Dec 31, 2019 | 0.59 |
| Sep 30, 2019 | 0.53 |
| Jun 30, 2019 | 0.56 |
| Mar 31, 2019 | 0.38 |
| Dec 31, 2018 | 0.37 |
| Sep 30, 2018 | 0.31 |
| Jun 30, 2018 | 0.40 |
| Mar 31, 2018 | 0.23 |
| Dec 31, 2017 | -0.48 |
| Sep 30, 2017 | 0.32 |
| Jun 30, 2017 | 0.16 |
| Mar 31, 2017 | 0.22 |
| Dec 31, 2016 | 0.53 |
| Sep 30, 2016 | -0.24 |
| Jun 30, 2016 | 0.40 |
| Mar 31, 2016 | 0.21 |
| Dec 31, 2015 | 0.46 |
| Sep 30, 2015 | 0.39 |
| Jun 30, 2015 | 0.52 |
| Mar 31, 2015 | 0.35 |
| Dec 31, 2014 | 0.59 |
| Sep 30, 2014 | 0.36 |
| Jun 30, 2014 | 0.28 |
| Mar 31, 2014 | 0.24 |
| Dec 31, 2013 | 0.37 |
| Sep 30, 2013 | 0.61 |
| Jun 30, 2013 | 0.30 |
| Mar 31, 2013 | 0.34 |
| Dec 31, 2012 | 0.66 |
| Sep 30, 2012 | 0.21 |
| Jun 30, 2012 | 1.08 |
| Mar 31, 2012 | 0.78 |
| Dec 31, 2011 | 1.02 |
| Sep 30, 2011 | 0.19 |
| Jun 30, 2011 | 1.23 |
| Mar 31, 2011 | 0.55 |
| Dec 31, 2010 | 0.92 |
| Sep 30, 2010 | 0.57 |
| Jun 30, 2010 | 0.83 |
| Mar 31, 2010 | 0.64 |
| Dec 31, 2009 | 0.98 |
| Sep 30, 2009 | 0.95 |
| Jun 30, 2009 | 0.83 |